Clinical Pharmacokinetics Study on Pikamilone

Study on the phamacokinetics of Pikamilone in healthy Chinese subject and provide informations for further phase II study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Observational

Primary location

the second hospital to liaoning university of TCM

Shenyang, Liaoning, 110034, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

nonsmokers and in good health
weight: BMI: 19-24
written informed consent was finished.

Exclusion criteria

disease
taking any drug, alcohol, foods containing caffeine, or grapefruits and juice before study.

Sponsors and collaborators

Lead sponsor

Chinese Academy of Sciences

Other Gov

Registry information

Important dates

Study start: 2009
Study completion: 2009
First posted: Jul 15, 2009
Registry last updated: Jul 15, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed